SG11201510814YA - O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof - Google Patents

O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof

Info

Publication number
SG11201510814YA
SG11201510814YA SG11201510814YA SG11201510814YA SG11201510814YA SG 11201510814Y A SG11201510814Y A SG 11201510814YA SG 11201510814Y A SG11201510814Y A SG 11201510814YA SG 11201510814Y A SG11201510814Y A SG 11201510814YA SG 11201510814Y A SG11201510814Y A SG 11201510814YA
Authority
SG
Singapore
Prior art keywords
mannosyltransferase
methods
filamentous fungal
fungal cells
deficient filamentous
Prior art date
Application number
SG11201510814YA
Inventor
Jari Natunen
Jukka Hiltunen
Anne Huuskonen
Markku Saloheimo
Christian Ostermeier
Benjamin Patrick Sommer
Ramon Wahl
Original Assignee
Novartis Ag
Glykos Finland Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48740957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201510814Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Glykos Finland Oy filed Critical Novartis Ag
Publication of SG11201510814YA publication Critical patent/SG11201510814YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01109—Dolichyl-phosphate-mannose-protein mannosyltransferase (2.4.1.109)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
SG11201510814YA 2013-07-04 2014-07-03 O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof SG11201510814YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13175141 2013-07-04
PCT/EP2014/064248 WO2015001049A1 (en) 2013-07-04 2014-07-03 O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof

Publications (1)

Publication Number Publication Date
SG11201510814YA true SG11201510814YA (en) 2016-01-28

Family

ID=48740957

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201510814YA SG11201510814YA (en) 2013-07-04 2014-07-03 O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof

Country Status (15)

Country Link
US (4) US20160376570A1 (en)
EP (1) EP3016970B1 (en)
KR (1) KR102111078B1 (en)
CN (1) CN105492457A (en)
BR (1) BR112015032695A2 (en)
CA (1) CA2916594C (en)
DK (1) DK3016970T3 (en)
ES (1) ES2739280T3 (en)
HR (1) HRP20191069T1 (en)
MX (1) MX364532B (en)
PL (1) PL3016970T3 (en)
RU (1) RU2016103373A (en)
SG (1) SG11201510814YA (en)
SI (1) SI3016970T1 (en)
WO (1) WO2015001049A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016012468A1 (en) 2014-07-21 2016-01-28 Novartis Ag Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
CA3113661A1 (en) * 2018-09-20 2020-03-26 Perfect Day, Inc. Methods and compositions for producing homokaryotic filamentous fungal cells
CA3121271A1 (en) * 2018-11-28 2020-06-04 Novozymes A/S Modified filamentous fungal host cells
CN110885810B (en) * 2019-12-16 2021-03-23 华中农业大学 Bacteriostatic protease CmYC1 prepared by eukaryotic fermentation and application thereof
CN115976033B (en) * 2022-12-14 2024-05-17 西南大学 Melon fly TSSK and TSSK genes and application thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4743546A (en) 1985-02-13 1988-05-10 Biotechnica International, Inc. Controlled gene excision
GB2276169A (en) 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
DE4244915C2 (en) 1992-08-14 1998-12-03 Widmar Prof Dr Tanner Fungal cells contg. mutated DPM2 mannosyl transferase gene
AU4424597A (en) 1996-09-13 1998-04-02 Novo Nordisk Biotech, Inc. Cells having dna insertion mutations which produce altered amounts of a polypeptide
DE19754622A1 (en) 1997-12-09 1999-06-10 Antje Von Dr Schaewen Plant GntI sequences and the use thereof for obtaining plants with reduced or missing N-acetylglucosaminyltransferase I (GnTI) activity
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
GB0021421D0 (en) 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds
BR0115912A (en) 2000-12-05 2005-10-18 Penn State Res Found Methods and compositions for the highly efficient production of heterologous yeast proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
BRPI0315943B1 (en) 2002-12-20 2019-07-09 Unilever N.V. METHOD FOR THE PRODUCTION OF ANTI-FROZEN PROTEIN
US20080292581A1 (en) 2003-12-03 2008-11-27 Delta Biotechnology Limited Interleukin-11 Fusion Proteins
HUE027902T2 (en) 2004-02-09 2016-11-28 Human Genome Sciences Inc Corp Service Company Albumin fusion proteins
WO2006036817A2 (en) 2004-09-24 2006-04-06 Microbia, Inc. Fungal variants and uses thereof
US7858360B2 (en) * 2005-10-17 2010-12-28 Novozymes A/S Use of fungal mutants for expression of antibodies
WO2007061631A2 (en) * 2005-11-15 2007-05-31 Glycofi, Inc Production of glycoproteins with reduced o-glycosylation
KR20090031359A (en) 2006-05-16 2009-03-25 교와 핫꼬 기린 가부시키가이샤 High secretion production method of protein
EP2102366A4 (en) 2006-12-10 2010-01-27 Dyadic International Inc Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi
GB0711424D0 (en) 2007-06-13 2007-07-25 Novozymes Delta Ltd Recombinant transferrin mutants
CA2695830A1 (en) 2007-08-08 2009-02-12 Novozymes Biopharma Dk A/S Transferrin variants and conjugates
EP2245151B1 (en) 2008-02-20 2014-12-24 GlycoFi, Inc. Vectors and yeast strains for protein production
US20090253173A1 (en) * 2008-04-08 2009-10-08 Danisco Us Inc., Genencor Division Filamentous fungi with inactivated protease genes for altered protein production
WO2009143041A1 (en) 2008-05-20 2009-11-26 Merck & Co., Inc. Efficient production of heterologous proteins using mannosyl transferase inhibitors
AU2009282228A1 (en) 2008-08-12 2010-02-18 Glycofi, Inc. Improved vectors and yeast strains for protein production: Ca2+ ATPase overexpression
WO2010034708A1 (en) 2008-09-23 2010-04-01 Unilever Plc A polynucleotide expression cassette
JP5936112B2 (en) 2009-02-11 2016-06-15 アルブミディクス アクティーゼルスカブ Albumin variants and complexes
CN102459330B (en) 2009-05-07 2014-11-05 诺维信生物制药丹麦公司 Method of controlling o-linked glycosylation of antibodies
CN102549012B (en) 2009-05-07 2015-07-01 诺维信生物制药丹麦公司 Method for purifying albumin
US8440456B2 (en) 2009-05-22 2013-05-14 Vib, Vzw Nucleic acids of Pichia pastoris and use thereof for recombinant production of proteins
WO2011046855A1 (en) 2009-10-16 2011-04-21 Merck Sharp & Dohme Corp. Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
MX2012006900A (en) 2009-12-18 2012-07-04 Novozymes Inc Methods for producing polypeptides in protease-deficient mutants of trichoderma.
JP5860413B2 (en) 2010-02-10 2016-02-16 バイオコン リミテッド Method for reducing glycosylation of protein, production method thereof and protein
CN102858949B (en) * 2010-02-24 2016-07-06 默沙东公司 For increasing the method that the N-glycosylation site on the therapeutic glycoprotein produced in pichia pastoris occupies
KR101818274B1 (en) 2010-05-27 2018-01-12 머크 샤프 앤드 돔 코포레이션 Method for preparing antibodies having improved properties
US20120135461A1 (en) 2010-07-30 2012-05-31 William James Cook Production of glycoproteins with reduced o-glycosylation comprising the use of an alpha-1,2-mannosidase
JP6017439B2 (en) 2010-11-24 2016-11-02 ノバルティス・インターナショナル・ファーマシューティカル・リミテッドＮｏｖａｒｔｉｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｌｔｄ． Fusion enzyme having N-acetylglucosaminyltransferase activity
JP5885191B2 (en) 2011-01-04 2016-03-15 国立研究開発法人産業技術総合研究所 Sugar chain-modified yeast and method for producing glycoprotein using the same
EP2678440B1 (en) 2011-02-25 2018-05-23 Merck Sharp & Dohme Corp. Yeast strain for the production of proteins with modified o-glycosylation
JP2014517846A (en) 2011-05-25 2014-07-24 メルク・シャープ・アンド・ドーム・コーポレーション Process for producing Fc-containing polypeptides having improved properties
AR087433A1 (en) 2011-08-08 2014-03-26 Merck Sharp & Dohme N-GLICOSILATED INSULIN ANALOGS
EP2771477A4 (en) 2011-10-27 2015-04-22 Merck Sharp & Dohme Controlling o-glycosylation in lower eukaryotes
EP2773661A4 (en) 2011-10-31 2015-06-17 Merck Sharp & Dohme Method for preparing antibodies having improved properties
WO2013066765A1 (en) 2011-11-01 2013-05-10 Merck Sharp & Dohme Corp. Mutation of tup1 in glycoengineered yeast
EP2780463A4 (en) 2011-11-18 2015-07-01 Merck Sharp & Dohme Fc CONTAINING POLYPEPTIDES HAVING INCREASED ANTI-INFLAMMATORY PROPERTIES AND INCREASED FcRN BINDING
WO2013174927A1 (en) * 2012-05-23 2013-11-28 Novartis International Pharmaceutical Limited Production of fucosylated glycoproteins
AU2013335065B2 (en) 2012-10-22 2018-10-25 Merck Sharp & Dohme Llc CRZ1 mutant fungal cells
US20150337274A1 (en) 2012-12-17 2015-11-26 Ming-Tang Chen Pmt2-, och1-, pmt5- mutant cells
WO2014126787A1 (en) 2013-02-13 2014-08-21 Merck Sharp & Dohme Corp. Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression
BR112015021960A2 (en) 2013-03-06 2017-08-29 Glaxosmithkline Llc HOST CELLS AND METHODS OF USE
EP2994483A4 (en) 2013-05-06 2017-02-08 Cell Machines, Inc. Methods and compositions related to large scale production of proteins
US20160115216A1 (en) 2013-06-07 2016-04-28 Novo Nordisk A/S Method for Making Mature Insulin Polypeptides
WO2015013116A1 (en) 2013-07-25 2015-01-29 Merck Sharp & Dohme Corp. Method for reducing the extent of o-mannosylation of glycoproteins
WO2015054039A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO FcGammaRIIB
WO2015073307A2 (en) 2013-11-13 2015-05-21 Merck Sharp & Dohme Corp. Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO HUMAN DC-SIGN

Also Published As

Publication number Publication date
RU2016103373A (en) 2017-08-10
KR20160030127A (en) 2016-03-16
PL3016970T3 (en) 2019-09-30
RU2016103373A3 (en) 2018-03-26
US10724013B2 (en) 2020-07-28
BR112015032695A2 (en) 2017-10-24
US20160376570A1 (en) 2016-12-29
US20220213451A1 (en) 2022-07-07
US20200040314A1 (en) 2020-02-06
MX364532B (en) 2019-04-29
CN105492457A (en) 2016-04-13
EP3016970B1 (en) 2019-05-22
ES2739280T3 (en) 2020-01-30
CA2916594C (en) 2020-03-10
CA2916594A1 (en) 2015-01-08
HRP20191069T1 (en) 2019-11-01
US20200362319A1 (en) 2020-11-19
DK3016970T3 (en) 2019-06-24
WO2015001049A1 (en) 2015-01-08
KR102111078B1 (en) 2020-05-18
SI3016970T1 (en) 2019-08-30
EP3016970A1 (en) 2016-05-11
MX2016000128A (en) 2016-03-01

Similar Documents

Publication Publication Date Title
IL243276A0 (en) Multiple proteases deficient filamentous fungal cells and methods of use thereof
HUS2200048I1 (en) Fcrn antagonists and methods of use
IL270347B (en) Therapeutically active compounds and their methods of use
IL233052A0 (en) Protease deficient filamentous fungal cells and methods of use thereof
HK1217948A1 (en) Therapeutically active compounds and their methods of use
HRP20170840T1 (en) Substituted xanthines and methods of use thereof
IL244296A0 (en) Cell penetrating conjugates and methods of use thereof
HK1223924A1 (en) Therapeutically active compounds and their methods of use
HRP20191069T1 (en) O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof
SG11201504771RA (en) Host cells and methods of use
IL245272A0 (en) Pif-transfected cells and methods of use
EP2943982A4 (en) Memory cells and methods of forming memory cells
EP2962339A4 (en) Batteries and methods of manufacturing batteries
IL224391A (en) Isolated and portable structure and method of its manufacture
AU2013901572A0 (en) Thermo-Electrochemical Cell and Method of Use
GB201319932D0 (en) Electrochemical materials and their manufacture
AU2013902844A0 (en) Three-dimensional electrodes and methods of fabrication